| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Clinical strategies for selecting oral anticoagulants in patients with atrial fibrillation
|
Pokorney, Sean D.
|
|
2013
|
36 |
2 |
p. 163-174
|
artikel
|
| 2 |
Measuring the anticoagulant effects of target specific oral anticoagulants—reasons, methods and current limitations
|
Mani, Helen
|
|
2013
|
36 |
2 |
p. 187-194
|
artikel
|
| 3 |
New oral anticoagulants: prevention of VTE in phase III studies in total joint replacement surgery and the hospitalized medically-ill patients
|
Galanis, Taki
|
|
2013
|
36 |
2 |
p. 141-148
|
artikel
|
| 4 |
Pharmacology of the new target-specific oral anticoagulants
|
Cabral, Katherine P.
|
|
2013
|
36 |
2 |
p. 133-140
|
artikel
|
| 5 |
Practical issues, limitations, and periprocedural management of the NOAC’s
|
Connolly, Gregory
|
|
2013
|
36 |
2 |
p. 212-222
|
artikel
|
| 6 |
Reversal of target-specific oral anticoagulants
|
Kaatz, Scott
|
|
2013
|
36 |
2 |
p. 195-202
|
artikel
|
| 7 |
Role of the new oral anticoagulants in treatment of venous throboembolism
|
Minichiello, Tracy
|
|
2013
|
36 |
2 |
p. 149-154
|
artikel
|
| 8 |
Role of the new target specific oral anticoagulants in the management of anticoagulation for cardioversion and atrial fibrillation ablation
|
Kowalski, Marcin
|
|
2013
|
36 |
2 |
p. 175-186
|
artikel
|
| 9 |
Target-specific oral anticoagulants in atrial fibrillation: results of phase III trials and comments on sub-analyses
|
Mantha, Simon
|
|
2013
|
36 |
2 |
p. 155-162
|
artikel
|
| 10 |
Target specific oral anticoagulants in the management of thromboembolic disease in the elderly
|
Maddula, Surekha
|
|
2013
|
36 |
2 |
p. 203-211
|
artikel
|
| 11 |
The new oral anticoagulants: results of clinical trials and practical applications
|
Ansell, Jack
|
|
2013
|
36 |
2 |
p. 131-132
|
artikel
|
Tijdschrift beschrijving